<DOC>
<DOCNO>
EP-0015065
</DOCNO>
<TEXT>
<DATE>
19800903
</DATE>
<IPC-CLASSIFICATIONS>
C07C-205/00 C07D-265/00 C07D-333/24 C07C-243/38 C07D-487/04 C07D-487/00 C07C-205/57 C07C-243/00 C07D-333/00 A61K-31/505 C07D-409/00 C07D-265/26 C07D-409/14 <main>C07D-487/04</main> 
</IPC-CLASSIFICATIONS>
<TITLE>
pyrazolo (5,1-b) quinazolin-9(4h)-one derivatives, process for their preparation and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
warner lambert cous<sep>warner-lambert company<sep>warner-lambert company201 tabor roadmorris plains new jersey 07950us<sep>warner-lambert company<sep>
</APPLICANT>
<INVENTOR>
capiris thomas<sep>kesten stephen jacob<sep>sircar jagadish chandra<sep>capiris, thomas<sep>kesten, stephen jacob<sep>sircar, jagadish chandra<sep>capiris, thomas14816 greenbriar courtplymouth, michigan 48170us<sep>kesten, stephen jacob3181 oak driveypsilanti, michigan 48197us<sep>sircar, jagadish chandra3615 charter placeann arbor, michigan 48105us<sep>capiris, thomas<sep>kesten, stephen jacob<sep>sircar, jagadish chandra<sep>capiris, thomas14816 greenbriar courtplymouth, michigan 48170us<sep>kesten, stephen jacob3181 oak driveypsilanti, michigan 48197us<sep>sircar, jagadish chandra3615 charter placeann arbor, michigan 48105us<sep>
</INVENTOR>
<ABSTRACT>
compounds of formula:    wherein x is hydrogen, hydroxy, alkyl, alkoxy halogen, trif­ luoromethyl, or sonr wherein r is alkyl and n is 0, 1 or 2; y is  hydrogen, hydroxy, alkyl, alkoxy, or 2-tetrahydrothienyl; r¹ is  hydrogen or alkyl, z is cooh,    their preparation and pharmaceutical compositions compris­ ing an anti-allergic effective amount of a compound of the  formula i.  
</ABSTRACT>
<DESCRIPTION>
substituted-pyrazolo [5,1-b]-quinazolin-9(4h)-ones, intermediates and method united states patents nos. 3,150,136 and 3,167,537 disclose, inter alia,certain pyrazoloquinazolone carboxylic acids whcih are useful as intermediates for the preparation of dyestuffs. german patent no. 1,111,505 discloses substituted 2-carboxy-pyrazolo- fs, 1-b quinazolin-9(4h)-ones which are useful as photographic colour developers. the references do not disclose or suggest any pharmaceutical utility for these acids, nor do they disclose the corresponding tetrazole or carboxamidotetrazole derivatives. according to the present invention there is provided a compound having the following general formula: emi1.1 wherein x is hydrogen, hydroxy, alkyl having from 1 to 6 carbon atoms, alkoxy having from 1 to 6 carbon atoms, halogen, trifluoromethyl, or sonr wherein r is alkyl having from 1 to 6 carbon atoms and n is 0, 1 or 2; y is hydrogen, hydroxy, alkyl having from 1 to 6 carbon atoms, alkoxy having from 1 to 6 carbon atoms, or 2-tetrahydrothienyl; r1 is hydrogen or alkyl having from 1 to 6 carbon atoms; z is cooh, emi2.1 or a pharmaceutically acceptable salt thereof; provided that when all of x, y and r1 are hydrogen, z is not cooh. preferred compounds are those having a compound having the following formula i: emi2.2 wherein x is hydrogen, hydroxy, methyl, methoxy, chlorine, fluorine or another halogen, or trifluoromethyl; r is hydrogen, methyl or ethyl; y is hydrogen or methoxy; z is -cooh, emi2.3 - r1 is hydrogen, methyl or ethyl; with the proviso that, when r1 is hydrogen and emi2.4 x is hydrogen, methyl, methoxy, chlorine, fluorine trifluoromethyl or hydroxy and y is hydrogen or, when x is methoxy, is methoxy; or with the proviso that, when r1is methyl or ethyl and z is emi3.1 y is hydrogen and x is hydrogen, methyl, methoxy or halogen; or with the proviso that, when z is emi3.2 r1 is hydrogen or methyl, x is hydrogen, methyl, methoxy, hydroxy, or chlorine, and y is hydrogen or, when r1 is methoxy, is methoxy: or a pharmaceutically acceptable salt thereof. the present invention also provides a pharmaceutical composition comprising an anti-allergic effective amount of a compound of the formula i: emi3.3 wherein x is hydrogen, hydroxy, alkyl having from 1 to 6 carbon atoms, alkoxy having from 1 to 6 carbon atoms, halogen, trifluoromethyl, or sonr wherein r is alkyl having from 1 to 6 carbon atoms, and n is 0,1 or 2; y is hydrogen, hydroxy, alkyl having from 1 to 6 carbon atoms, alkoxy having from 1 to 6 carbon atoms, or 2-tetrahydrothienyl; r1 is hydrogen or alkyl having from 1 to 6 carbon atoms; y is cool, emi3.4 or a pharmaceutically acceptable salt thereof: and a diluent or carrier for that compound or salt thereof. the present invention provides a method of preventing the allergic response in a mammal which comprises administering to said mamal an anti-allergic effective amount of a compound of formula i or a pharmaceutically acceptable salt thereof. the present invention also provides a compound of the formula ii: emi4.1 wherein r2 is alkyl
</DESCRIPTION>
<CLAIMS>
claims:    1. a compound having the following general formula: emi47.1       wherein x is hydrogen, hydroxy, alkyl having from 1 to 6 carbon atoms, alkoxy having from 1 to 6 carbon atoms, halogen, trifluoromethyl, or   sonr    wherein r is alkyl having from 1 to 6 carbon atoms and n is 0,   l    or 2; y is hydrogen, hydroxy, alkyl having from 1 to 6 carbon atoms, alkoxy having from 1 to 6 carbon atoms, or 2-tetrahydrothienyl; r1 is hydrogen or alkyl having from 1 to 6 carbon atoms; z is cooh, emi47.2         or a    pharmaceutically acceptable salt thereof; provided that when all of x,y and r1 are hydrogen, z is not cooh.    2. a compound having formula i as defined in claim 1, wherein z is emi47.3       or a pharmaceutically acceptable salt thereof.    3. a compound having the following formula i:  3. a compound having the following-formula i: emi48.1       wherein x is hydrogen,. hydroxy, methyl, methoxy, chlorine fluorine or another halogen, or trifluoromethyl;   rl is    hydrogen, methyl or ethyl; y is hydrogen or methoxy; z is -cooh, emi48.2         rl    is hydrogen, methyl or ethyl; with the proviso that, when r1 is hydrogen and emi48.3       x is hydrogen, methyl, methoxy, chlorine, fluorine, trifluoromethyl or hydroxy and y is hydrogen or, when x is methoxy, is methoxy; or with the proviso that, when   r1    is methyl or ethyl and z is emi48.4       y is hydrogen and   x is    hydrogen, methyl, methoxy or halogen;  or with the proviso that, when z is   emi49.1       r1 is hydrogen or methyl, x is hydrogen, methyl, methoxy, hydroxy, or chlorine, and y is hydrogen or, when   rl is methoxy, is    methoxy: or a pharmaceutically acceptable salt thereof.    4. a pharmaceutical composition comprising an anti-allergic effective amount of a compound of the formula i: emi49.2       wherein x is hydrogen, hydroxy, alkyl having from 1 to 6 carbon atoms, alkoxy having from 1 to 6 carbon atoms, halogen, trifluoromethyl, or sonr wherein r is alkyl having from 1 to 6 carbon atoms and n is 0, 1 or 2; y is hydrogen, hydroxy; alkyl having from 1 to 6 carbon atoms, alkoxy having from   l    to 6 carbon atoms, or 2-tetrahydrothienyl; r1 is hydrogen or alkyl having from 1 to 6 carbon atoms; z is   cool,    emi49.3       or a pharmaceutically acceptable salt thereof: and a diluent or carrier for that compound or salt thereof.    5. a pharmaceutical composition as claimed in claim 4, wherein z is emi49.4          6. a pharmaceutical composition as claimed in claim 4, wherein z is   cool.       7. a pharmaceutical composition comprising a compound as claimed in claim 3, and a carrier or diluent therefor .    8. a process for preparing a compound of the formula emi50.1       wherein x is hydrogen, hydroxy, alkyl having from 1 to 6 carbon atoms, alkoxy having from 1 to 6 carbon atoms,   halogenatrifluoromethyl    or so r wherein r is alkyl having from   l    to 6 carbon atoms and n is 0, 1 or 2; y is hydrogen, hydroxy, alkyl having from   i.to      6 carbon    atoms, alkoxy having from 1 to 6 carbon atoms, or 2-tetrahydrothienyl; r1 is alkyl having from   i    to 6 carbon atoms; and ra is alkyl having from 1 to 6 carbon atoms; which comprises reacting a   3-alkoxyearbonyl-2-pyrazolin-    5-one of the formula emi50.2       wherein ra is as defined above, with a substituted n-alkyl isotoic anhydride of the formula; emi50.3        where   x,u    and   r1    are as defined above, and isolating the product.    9. a process according to claim 8, which further comprises hydrolyzing the ester function,   coora,    and isolating the carboxylic acid so produced.       10.    a process for preparing a compound of the formula emi51.1       wherein x is hydrogen, hydroxy, alkyl having from 1 to 6 carbon atoms, alkoxy having from 1 to 6 carbon atoms,   halogenltrifluoromethyl,    or sonr   wherein    is alkyl having from 1 to 6 carbon atoms and n is 0, 1 or 2; y is hydrogen, hydroxy, alkyl having from 1 to 6 carbon atoms, alkoxy having from   l    to 6 carbon atoms, or 2-tetrahydrothienyl; and   rb    is alkyl having from 1 to 6 carbon atoms; which comprises reacting a 2-aminobenzoic acid hydrazide of the formula emi51.2       with a dialkyl oxalacetate; and isolating the product; and optionally hydrolyzing the ester function, coorb, and isolating the carboxylic acid so produced.  
</CLAIMS>
</TEXT>
</DOC>
